These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26362590)

  • 1. Early vs. late reverse ventricular remodeling in patients with cardiomyopathy.
    Banno A; Kohsaka S; Inohara T; Koide K; Shiraishi Y; Kohno T; Sano M; Yoshikawa T; Fukuda K
    J Cardiol; 2016 Jul; 68(1):57-63. PubMed ID: 26362590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.
    Adamo M; Godino C; Giannini C; Scotti A; Liga R; Curello S; Fiorina C; Chiari E; Chizzola G; Abbenante A; Visco E; Branca L; Fiorelli F; Agricola E; Stella S; Lombardi C; Colombo A; Petronio AS; Metra M; Ettori F
    Eur J Heart Fail; 2019 Feb; 21(2):196-204. PubMed ID: 30549159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of body composition in left ventricular remodeling, reverse remodeling, and clinical outcomes for heart failure with mildly reduced ejection fraction: more knowledge to the "obesity paradox".
    Fu K; Dong Y; Wang Z; Teng J; Cheng C; Su C; Ji X; Lu H
    Cardiovasc Diabetol; 2024 Sep; 23(1):334. PubMed ID: 39261931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy.
    Merlo M; Masè M; Vitrella G; Belgrano M; Faganello G; Di Giusto F; Boscutti A; Gobbo M; Gigli M; Altinier A; Lesizza P; Barbati G; Ramani F; De Luca A; Morea G; Cova MA; Stolfo D; Sinagra G
    Am J Cardiol; 2018 Aug; 122(3):490-497. PubMed ID: 29958711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of spontaneous reverse remodeling in mild heart failure patients with left ventricular dysfunction.
    Brenyo A; Barsheshet A; Kutyifa V; Ruwald AC; Rao M; Zareba W; Pouleur AC; Knappe D; Solomon SD; McNitt S; Huang DT; Moss AJ; Goldenberg I
    Circ Heart Fail; 2014 Jul; 7(4):565-72. PubMed ID: 24786217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.
    Cescau A; Van Aelst LNL; Baudet M; Cohen Solal A; Logeart D
    ESC Heart Fail; 2017 Nov; 4(4):686-689. PubMed ID: 28752617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.
    Ruiz-Zamora I; Rodriguez-Capitan J; Guerrero-Molina A; Morcillo-Hidalgo L; Rodriguez-Bailon I; Gomez-Doblas JJ; de Teresa-Galvan E; Garcia-Pinilla JM
    Int J Cardiol; 2016 Jan; 203():1114-21. PubMed ID: 26651150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of left ventricular reverse remodelling and recurrent mitral regurgitation after personalized surgical treatment of patients with non-ischaemic cardiomyopathy and functional mitral regurgitation.
    Petrus AHJ; Tops LF; Timmer E; Versteegh MIM; Dekkers OM; Klautz RJM; Braun J
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):657-663. PubMed ID: 29788278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Late Gadolinium Enhancement with or Without Reverse Remodeling and Prognosis.
    Kawakami T; Yahagi K; Oshima A; Gonda Y; Yoshiura D; Horiuchi Y; Asami M; Yuzawa H; Komiyama K; Tanaka J; Aoki J; Tanabe K
    Int Heart J; 2024; 65(4):676-683. PubMed ID: 39085108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and predictors of left ventricular reverse remodeling in patients with recent onset dilated cardiomyopathy on tailored medical therapy].
    Zhang J; Zou CH; Huang Y; Zhou Q; Zhang YH; Lyu R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):315-20. PubMed ID: 27112609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, predictors and prognosis of ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Amorim S; Campelo M; Martins E; Moura B; Sousa A; Pinho T; Silva-Cardoso J; Maciel MJ
    Rev Port Cardiol; 2016 May; 35(5):253-60. PubMed ID: 27118094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrabeculation is associated with improvement in systolic function and favorable prognosis in adult patients with non-ischemic cardiomyopathy.
    Minamisawa M; Koyama J; Kozuka A; Miura T; Ebisawa S; Motoki H; Okada A; Izawa A; Ikeda U
    J Cardiol; 2016 Nov; 68(5):431-438. PubMed ID: 26740463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Dose β-Blocker Therapy Triggers Additional Reverse Remodeling in Patients With Idiopathic Non-Ischemic Cardiomyopathy.
    Nitta D; Kinugawa K; Imamura T; Kato NP; Komuro I
    Int Heart J; 2016 Dec; 57(6):717-724. PubMed ID: 27818482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
    Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
    Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Fujita T; Iida Y; Nabeta T; Ishii S; Maekawa E; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Nov; 31(11):1817-1825. PubMed ID: 26843195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy.
    Choi JO; Kim EY; Lee GY; Lee SC; Park SW; Kim DK; Oh JK; Jeon ES
    Circ J; 2013; 77(2):462-9. PubMed ID: 23095684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epicardial adipose tissue volume is an independent predictor of left ventricular reverse remodeling in patients with non-ischemic cardiomyopathy.
    Yamaguchi Y; Shibata A; Yoshida T; Tanihata A; Hayashi H; Kitada R; Ehara S; Izumiya Y; Fukuda D
    Int J Cardiol; 2022 Jun; 356():60-65. PubMed ID: 35358639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to left ventricular reverse remodeling after cardiac resynchronization therapy: Better late than never.
    Viveiros Monteiro A; Martins Oliveira M; Silva Cunha P; Nogueira da Silva M; Feliciano J; Branco L; Rio P; Pimenta R; Delgado AS; Cruz Ferreira R
    Rev Port Cardiol; 2016 Mar; 35(3):161-7. PubMed ID: 26923367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.